Author

S. Gregoricchio

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

K. Schuurman· 2 shared W. Zwart· 2 shared A. A. Singh· 1 shared A. Kojic· 1 shared A. M. Bergman· 1 shared A. Zaalberg· 1 shared C. Lieftink· 1 shared D. Li· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Schuurman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhancer plasticity in endometrial tumorigenesis demarcates non-coding somatic mutations and 3D-genome alterations boosting the oncogenic driver ESR1

S. Gregoricchio, A. Kojic, M. Hoogstraat, K. Schuurman, S. Stelloo, T. M. Severson, T. A. O'Mara, M. Droog, A. A. Singh, D. M. Glubb, L. F. A. Wessels, M. Vermeulen, F. van Leeuwen, W. Zwart

The paper identifies enhancer plasticity and 3D-genome alterations in endometrial cancer that boost ESR1 expression through non-coding mutations and risk variants.

bioRxiv · Jul 25, 2023Cancer Biology

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator

A. Zaalberg, E. Minnee, I. Mayayo-Peralta, K. Schuurman, S. Gregoricchio, T. A. van Schaik, L. Hoekman, D. Li, E. Corey, H. Janssen, C. Lieftink, S. Prekovic, M. Altelaar, P. S. Nelson, R. Beijersbergen, , A. M. Bergman

This study uses a CRISPR screen to identify genes critical for macrophage-mediated killing of prostate cancer cells, revealing AR as an immunomodulator that promotes resistance to macrophage attack.

bioRxiv · Jun 6, 2023Cancer Biology